Statement by Dr. Eugen Hug, Chief Medical Officer of ProCureTreatment Centers, Regarding the University of North Carolina Study Comparing Proton Therapy and Intensity Modulated Radiation Therapy (IMRT) for Prostate Cancer

BLOOMINGTON, Ind.--(BUSINESS WIRE)--The following is a statement by Dr. Eugen Hug: A controversial conclusion reached in the study “Comparative effectiveness of intensity modulated radiation therapy, proton therapy and conformal radiation therapy in the treatment of localized prostate cancer” is firmly contradicted by a number of well-regarded peer-reviewed studies that found protons reduce – not increase – gastrointestinal side effects. The UNC study runs counter to what we know from these studies, from research being carried out by ProCure and other proton centers and from our first-hand experience treating hundreds of patients with this important cancer therapy.